Full-Time
Account Executive
Ruminant Nutrition
Ajinomoto Health & Nutrition North America
Compensation Overview
$155k - $160k/yr
New York, NY, USA
In Person
Bachelor's
 Sales & Account Management (1) |
|---|
- A bachelor's degree in animal nutrition, animal science, or a related field is desired.
- At least 5 years of proven business-to-business sales experience in animal nutrition, feed additives, or technical sales or support, preferably involving swine, poultry, or dairy.
- Strong knowledge of ruminant nutrition, preferably dairy or beef.
- Strong written and verbal communication skills.
- Demonstrable experience negotiating and meeting client requirements.
- Strong analytical and organizational skills.
- Experience using customer relationship management systems.
- Ability to travel up to 50%, including overnight travel.
- Experience in public speaking and creating and delivering professional presentations.
- Ability to solve problems and work cross-functionally to service customers effectively.
- A valid passport.
- Knowledge of the North American livestock business.
- Knowledge of customer service and quality standards.
- Develop and execute agent-level sales strategies for AjiPro-L and animal feed amino acids across North America and other global markets, including Brazil and China.
- Identify customer needs and growth opportunities by qualifying and quantifying target accounts by product category.
- Drive sales growth through direct customer engagement and distributor management.
- Establish and achieve budgets for sales volume plans, implementing countermeasures when gaps occur.
- Help create and prepare budgets by establishing and implementing short- and long-term plans with teams in the United States and Japan.
- Provide verbal and written communications to sales agents and customers to maintain rapport and drive timely communications for pricing actions.
- Understand, analyze, and manage information sources to support sales strategies, pricing decisions, and product marketing, including customer, agent, import/export, commodity-market, and nutritional-staff data.
- Build relationships with customers, agents, and distributors to maintain and improve long-term business development.
- Engage with the Technical Department to align nutritional changes, sales dynamics, and market trends with commercial strategies.
- Understand customer profitability and implement strategies to improve it.
- Ensure customer satisfaction by understanding standards, resolving problems, and making periodic customer visits to identify trends and customer needs.
- Collect, analyze, and summarize data and trends to provide timely and critical information.
- Analyze supply-and-demand drivers, competitor products, market share, strengths, weaknesses, and activities to anticipate opportunities, drive sales growth, and maximize profit.
- Update, complete, and analyze weekly and monthly reports, including import/export data and supply-and-demand forecast analyses.
- Work with the North American Technical Department to develop new product ideas, strategies, and marketing materials.
- Assist with North American accounts receivable and collections through agents.
- Provide support to the Business Unit Director as required.
- Perform other duties as assigned.
- Experience working with nutritionists and feed mills.
- Knowledge of lysine or amino acid products.
- Familiarity with feed formulation and farm economics.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
N/A
Simplify's Take
What believers are saying
- June 22, 2026 Syntax Bio collaboration broadens StemFit into cell-therapy development.
- June 4, 2025 Raleigh lab renovation upgraded analytics, workflow, and safety.
- June 23, 2025 Salt Answer and Palate Perfect target sodium reduction and formulation wins.
What critics are saying
- Akron's roughly $14.5 million expansion depends on 2025 city negotiations and December 2026 completion.
- StemFit's commercial value still depends on Syntax Bio validation, not revenue.
- If fermented flavor platforms stall, AHN remains trapped in commodity amino-acid pricing.
What makes Ajinomoto Health & Nutrition North America unique
- Ajinomoto's amino-acid science spans food, pharma, nutraceutical, and cell-culture applications.
- StemFit chemically defined media supports reproducible stem-cell workflows for regenerative medicine.
- Salt Answer and Palate Perfect use proprietary umami, kokumi, and fermentation technologies.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Paid Vacation
Paid Holidays
Parental Leave
Flexible Work Hours
Wellness Program
Life Insurance
Disability Insurance
Tuition Reimbursement
Mental Health Support
Professional Development Budget
Company News
Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. collaborate to evaluate stem cell culture technologies using Cellgorithm(TM) platform. The collaboration will evaluate Ajinomoto Group's stem cell culture products using Syntax Bio's programmable stem cell differentiation platform to support improved regenerative medicine discovery, development, and manufacturing. CHICAGO & ITASCA, Ill.-(BUSINESS WIRE)-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group's StemFit(TM) stem cell culture products using Syntax Bio's proprietary Cellgorithm(TM) platform. Syntax Bio and Ajinomoto Health & Nutrition North America are collaborating to evaluate stem cell culture technologies that could enhance the performance, consistency and scalability of regenerative medicine discovery, development and manufacturing. Share Through the collaboration, AHN is providing Syntax Bio with StemFit(TM) stem cell culture media products to demonstrate Cellgorithm(TM) compatibility, performance and workflow optimization. Syntax Bio will evaluate StemFit(TM) and generate data to support their growing pipeline of cell therapy collaborations. "We are excited to support Syntax Bio's innovative approach to stem cell differentiation," said Michael Lish, President & CEO of Ajinomoto Health & Nutrition North America, Inc. "StemFit(TM) provides a highly controlled and reliable culture environment that is well-suited to complement advanced platforms like Cellgorithm(TM). By supporting a smooth transition from research workflows and potentially toward manufacturing applications, we believe our solutions can help accelerate the development of next-generation cell therapies." "The development of cell therapies depends on having compatible and reproducible technologies across every stage of the workflow, including the environments used to grow and maintain cells," said John Craighead, Ph.D., CEO of Syntax Bio. "Collaborating with Ajinomoto Group gives us the opportunity to evaluate high-performance stem cell culture products using our Cellgorithm(TM) platform to enhance efficiency, consistency, and scale across many regenerative medicine applications." Cellgorithm(TM) technology simplifies stem cell differentiation by programming the sequence of gene activations needed to create specific cell types. The platform reduces the need for repeated manual interventions and has demonstrated the ability to generate target cell types in days or weeks rather than months. Through collaborations with innovators such as Syntax Bio, Ajinomoto Group aims to explore expanding the use of StemFit(TM) into more advanced cell development and potential future manufacturing processes. This initiative supports the company's broader goal of advancing regenerative medicine with high-quality solutions that improve reliability, safety, and scalability across cell therapy development and production. About Syntax Bio Syntax Bio is a synthetic biology company programming the next generation of cell therapies. Its proprietary Cellgorithm(TM) platform uses a CRISPR-based system to program and accelerate stem cell differentiation, transforming how regenerative medicines are discovered, developed, and manufactured. By replacing slow, labor-intensive differentiation processes with a rapid, programmable approach that mimics human development, Syntax Bio makes cellular generation more reliable and scalable at unprecedented speed, unlocking new possibilities across the biotechnology industry. Learn more at www.syntaxbio.com. About Ajinomoto Health & Nutrition North America, Inc. Ajinomoto Health & Nutrition North America, Inc. is a wholly-owned subsidiary of Ajinomoto Group, a global leader in amino acid science and the research, development, manufacture, and sale of amino acid-based products across pharmaceutical, nutraceutical, sports nutrition, health and beauty, and food industries. Building on its long-standing expertise in amino acid technologies, the company is advancing regenerative medicine by providing high-quality, chemically defined stem cell culture media, including the StemFit(TM) series, which supports the development of safe, reliable, and scalable cell therapies. For additional information, please visit www.ajihealthandnutrition.com. Contacts. Ajinomoto Health & Nutrition North America, Inc. Kimberly Kennedy [email protected] More News From Syntax Bio CHICAGO-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of directors and scientific advisory board. The expansion brings Syntax Bio's Series A to $14.4 million and total funding to over $25 million. The expanded round builds on support from Astellas Venture Management, Illumina Ventures, DCVC Bio, Civilization Ventures, EGB Capital, Mansu... CHICAGO-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on advancing stem cell-derived pancreatic cell therapies for type 1 diabetes. Under the collaboration, the teams seek to define and develop an allogeneic pancreatic beta cell therapy for insulin-dependent diabetes based on patient needs. Syntax Bio plans to use its proprietary CellgorithmTM platform to gui... CHICAGO & NEW YORK-( BUSINESS WIRE )-Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an award of up to $856,250 from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, under its Industry Discovery and Development Partnership (IDDP) program to advance a pancreatic beta cell therapy targeting T1D using its Cellgorithm platform technology. "The daily burden for those living with t...
RALEIGH, N.C., June 4, 2025 /PRNewswire/ -- Ajinomoto Health & Nutrition North America, Inc. (AHN), a global leader in amino acid manufacturing, celebrated the opening of its renovated Quality Control Laboratory today with a ribbon-cutting ceremony.Global senior leaders and dedicated team members who have been integral to the renovation efforts gathered at the modern facility on AHN's Raleigh, North Carolina, campus. The re-envisioned lab showcases AHN's commitment to delivering top product quality and leading safety standards."By updating our facilities, we are even more equipped to meet the evolving needs of our customers and maintain our position as a leader in the industry," said Jessica Lee, Quality Manager. "Our Quality Control Laboratory is part of Ajinomoto Health and Nutrition's ongoing investment in quality and innovation."With the expanding need for amino acids in today's market, AHN's Quality Control Laboratory features advanced analytical equipment, improved workflow efficiencies, and enhanced safety measures. The facility benefits from Raleigh's skilled workforce, top universities, and numerous life sciences support companies, strengthening the area's reputation as a leading biotech hub.The enhancements also support AHN's growth plan for supplying Active Pharmaceutical Ingredient (API) amino acids and blends globally.By investing in these upgrades, AHN is positioning itself to meet the increasing global demand for high-quality APIs. The improved laboratory enables AHN to scale production and maintain stringent quality standards across larger volumes
CAMBRIDGE, Mass., Feb. 11, 2025 /PRNewswire/ -- Ajinomoto Co., Inc., a global leader in biotechnology and food innovation, proudly announces its sponsorship of LabCentral, a premier launchpad for high-potential life sciences and biotech startups located in the heart of the Greater Boston biotechnology community. This partnership underscores the Ajinomoto Group's commitment to fostering innovation, collaboration, and scientific advancement in this rapidly evolving sector and thriving ecosystem.The sponsorship is in full alignment with the Ajinomoto Group's purpose to contribute to the well-being of all human beings, our society, and our planet with "AminoScience" and its cutting-edge technologies, including innovations in cell and gene therapy, amino acid, and protein sciences. The Ajinomoto Innovation Strategy Development Team in particular is fully committed to supporting the thriving biotech ecosystem in Cambridge and Massachusetts.LabCentral, located in Cambridge, provides startups with the laboratory space, resources, and community necessary to translate breakthrough ideas into viable solutions. The Ajinomoto Group's sponsorship will enhance LabCentral's ability to support promising ventures in areas such as drug discovery, cell and gene therapy, and other transformative life sciences fields."LabCentral represents the nexus of innovation and opportunity in biotech, and the Ajinomoto Group is honored to support its mission of empowering next-generation startups," said Dr. Ikuo Kira, Executive Officer & Vice President, General Manager, North America Division
Protein discovery startup Shiru has teamed up with Ajinomoto Health Nutrition Partners, part of ingredients giant Ajinomoto, to develop and commercialize sweet proteins: high intensity natural sweeteners that can replace sugar in beverages and other products. Natural sweeteners such as stevia and monk fruit have improved significantly in recent years. However, sweet proteins—which are found in fruits and berries that grow near the equator and can be up to 5,000x sweeter than sugar with no impact on blood glucose—add an exciting new dimension to the natural sugar-reduction toolbox, Shiru founder and CEO Dr. Jasmin Hume told AgFunderNews. The challenge, she says, has been two-fold. First, identifying proteins in nature with the right kind of sweetness (without linger, stability issues, etc)
Shiru and Ajinomoto Health & Nutrition partner to develop sweet proteins that can replace sugar.